CSIMarket
 


Singular Genomics Systems Inc   (OMIC)
Other Ticker:  
 

Singular Genomics Systems Inc 's Quick Ratio

OMIC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 24.62 a new company low.

Within Laboratory Analytical Instruments industry only one company has achieved higher Quick Ratio in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 57 to 94.

Explain Quick Ratio?
How much Cash & cash equivalents OMIC´s has?
What are OMIC´s Current Liabilities?


OMIC Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change -8.59 % -21.43 % -13.95 % 15.58 % 41.46 %
Y / Y Cash & cash equivalent Change -27.71 % -28.11 % -28.45 % -27.9 % -26.1 %
Quick Ratio MRQ 24.62 32.58 40.82 31.38 31.13
OMIC's Total Ranking # 94 # 57 # 71 # 88 # 107
Seq. Current Liabilities Change 22.13 % 14.54 % -28.95 % -8.02 % 4.98 %
Seq. Cash & cash equivalent Change -7.72 % -8.58 % -7.57 % -7.3 % -8.23 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 31
Overall Market # 94


Quick Ratio Statistics
High Average Low
59.59 40.07 24.62
(Sep 30 2021)   (Sep 30 2023)




Financial Statements
Singular Genomics Systems Inc 's Current Liabilities $ 8 Millions Visit OMIC's Balance sheet
Singular Genomics Systems Inc 's Cash & cash equivalent $ 191 Millions Visit OMIC's Balance sheet
Source of OMIC's Sales Visit OMIC's Sales by Geography


Cumulative Singular Genomics Systems Inc 's Quick Ratio

OMIC's Quick Ratio for the trailling 12 Months

OMIC Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth -8.59 % -21.43 % -13.95 % 15.58 % 41.46 %
Y / Y Cash & cash equivalent TTM Growth -27.71 % -28.11 % -28.45 % -27.9 % -26.1 %
Quick Ratio TTM 31.65 33.43 34.2 36.12 40.59
Total Ranking TTM # 39 # 2876 # 2782 # 3244 # 59
Seq. Current Liabilities TTM Growth 22.13 % 14.54 % -28.95 % -8.02 % 4.98 %
Seq. Cash & cash equivalent TTM Growth -7.72 % -8.58 % -7.57 % -7.3 % -8.23 %


On the trailing twelve months basis In spite of the year on year decrease in OMIC's Current Liabilities to $7.75 millions, cumulative Quick Ratio to 31.65 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry OMIC achieved the highest Quick Ratio. While Quick Ratio overall ranking has improved so far to 39, from total ranking during the twelve months ending second quarter 2023 at 2876.

Explain Quick Ratio?
How much Cash & cash equivalents OMIC´s has?
What are OMIC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 25
Within the Market # 39


trailing twelve months Quick Ratio Statistics
High Average Low
46.18 27.9 15.5
(Mar 31 2022)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Laboratory Analytical Instruments Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Seer Inc   26.46 $ 331.248  Millions$ 12.518  Millions
Singular Genomics Systems Inc   24.62 $ 190.717  Millions$ 7.747  Millions
Nautilus Biotechnology Inc   20.61 $ 183.289  Millions$ 8.894  Millions
Astrotech Corp  17.33 $ 38.953  Millions$ 2.248  Millions
Talis Biomedical Corporation  10.41 $ 87.996  Millions$ 8.450  Millions
Quanterix Corp  9.32 $ 327.710  Millions$ 35.153  Millions
Rapid Micro Biosystems Inc   5.72 $ 89.389  Millions$ 15.618  Millions

Date modified: 2023-11-16T18:32:53+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com